Zimmer Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated January 29, 2007, reports the results of operations for Zimmer Holdings, Inc. for the quarter and full year ended December 31, 2006. The company is headquartered in Warsaw, Indiana, and operates in the medical technology sector, having previously acquired Centerpulse AG (2003) and Implex Corp. (2004).
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Press Release (Exhibit 99.1), which is incorporated by reference. The company reports both GAAP and non-GAAP financial measures, including adjusted net earnings, adjusted diluted EPS, adjusted net margin, adjusted operating margin, and adjusted gross margin. Additionally, the company reports sales performance using constant currency sales to exclude foreign exchange rate fluctuations.
Material Changes and Accounting Adjustments
- Acquisition-Related Items: Non-GAAP measures exclude acquisition, integration, and other expenses, as well as inventory step-up costs.
- SFAS 123(R) Adoption: Financial results include share-based payment expenses resulting from the adoption of Statement of Financial Accounting Standard No. 123 (revised 2004). The company provides adjusted non-GAAP measures excluding these costs to facilitate comparison with prior periods.
- Currency Impact: Constant currency sales are presented to isolate organic growth from foreign currency exchange rate changes.
Guidance, Outlook, and Risks
The filing references projected adjusted diluted EPS within the attached press release but does not detail specific guidance figures in the text of this Form 8-K. Management emphasizes that non-GAAP measures should be considered in addition to, not as a substitute for, GAAP measures. The filing includes standard disclaimers that the information is furnished, not filed, and makes no admission as to the materiality of the information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for the quarter and year ended December 31, 2006.
- Verify the reconciliation between non-GAAP adjusted measures and the most directly comparable GAAP measures as required by SEC rules.
- Assess the impact of SFAS 123(R) share-based payment expenses on net earnings compared to prior periods.
- Examine the constant currency sales calculation methodology to understand organic growth trends versus currency effects.
- Confirm the specific projected adjusted diluted EPS figures mentioned in the press release.